Imperforate hymen with elevated serum CA 125 and CA 19-9 levels

• Published in: Journal of reproductive medicine Vol. 58; no. 1-2; p. 47
• Main Authors: Sak, Muhammet Erdal, Evsen, Mehmet Siddik, Soydinc, Hatice Ender, Sak, Sibel, Yalinkaya, Ahmet
• Format: Journal Article
• Language: English
• Published: United States 01.01.2013
• Subjects: Adolescent; Amenorrhea - complications; Biomarkers, Tumor - blood; CA-125 Antigen - blood; CA-19-9 Antigen - blood; Child; Constipation - complications; Female; Hematocolpos - complications; Hematometra - complications; Humans; Hymen - abnormalities; Hymen - surgery; Membrane Proteins - blood; Menstruation Disturbances - blood; Menstruation Disturbances - complications; Menstruation Disturbances - surgery; Pelvic Pain - complications; Retrospective Studies; Urination Disorders - complications
• ISSN: 0024-7758

To report the clinical characteristics of 14 patients with imperforate hymen and their levels of tumor markers (CA 19-9 and CA 125). Fourteen patients with imperforate hymen who followed-up between September 2006 and September 2010 in the Department of Obstetrics and Gynecology, Dicle University School of Medicine, Diyarbakir, Turkey, were evaluated retrospectively. The clinical features and the management of the patients are discussed. The mean age of the patients was 13.8 years. All patients had primary amenorrhea and pelvic pain. The most common clinical symptoms were cryptomenorrhea in 14 patients, pelvic pain in 11, palpable abdominal mass in 6, voiding difficulties in 7, and defecation problems in 2. In 6 patients with palpable pelvic mass, the mean + standard deviation values of tumor markers were as follows: CA 125, 84.0 +/- 23.7 and CA 19-9, 162 +/- 189. One week after surgery we measured CA 125 and CA 19-9 levels once again. The postoperative mean CA 125 level was 13.8 +/- 3.6, and the mean postoperative CA 19-9 level was 17.5 +/- 3.5. Preoperative levels of CA 125 and CA 19-9 were significantly higher than those of the postoperative period (p < 0.001 for both comparisons). Six patients were treated by T-shaped incision and 8 patients by a central surgical incision through the hymenal membrane. Diagnosis of imperforate hymen is very important before undergoing surgery in a different clinic. Many patients have seen several doctors before receiving a clear diagnosis and have had tumor markers evaluated because the presence of pelvic mass in patients suggests the possibility of a gynecologic malignancy. Imperforate hymen is one of the benign conditions that increase serum CA 125 and CA 19-9 levels and which is not listed in the classical medical textbooks. These markers are not needed for the diagnosis.